SCHEMBL17349933

CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CS)C(N)=O

nearest known ligand 0.63

Predicted protein targets (top 2)

	gene	UniProt	supporting neighbours	confidence
▸	KISS1R	Q969F8	19/20	0.63

▸	IL23R	Q5VWK5	1/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL16421675	0.96	KISS1R (0.62)	KISS1R
SCHEMBL17849829	0.93	KISS1R (0.56)	KISS1R
SCHEMBL17849805	0.93	KISS1R (0.56)	KISS1R
SCHEMBL21754038	0.93	KISS1R (0.56)	KISS1R
SCHEMBL29975121	0.89	KISS1R (0.63)	KISS1RIL23R
SCHEMBL30420969	0.89	KISS1R (0.76)	KISS1R
SCHEMBL30420873	0.89	KISS1R (0.76)	KISS1R
SCHEMBL30420870	0.89	KISS1R (0.76)	KISS1R
SCHEMBL30421283	0.89	KISS1R (0.76)	KISS1R
SCHEMBL30420526	0.89	KISS1R (0.76)	KISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-9782498-B2	Selective delivery molecules and methods of use	AVELAS BIOSCIENCES, INC. (US)	2017-10-10	—	—	US	disclosed
US-20150359908-A1	SELECTIVE DELIVERY MOLECULES AND METHODS OF USE	AVELAS ACQUISITION CORPORATION	2015-12-17	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20150359908-A1	SELECTIVE DELIVERY MOLECULES AND METHODS OF USE	SLC2A8, CD44, SLC2A3	KISS1R 1842/4885IL23R 3787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.